Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/28201
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLancaster, T-
dc.contributor.authorCreese, B-
dc.contributor.authorEscott-Price, V-
dc.contributor.authorDriver, I-
dc.contributor.authorMenzies, G-
dc.contributor.authorKhan, Z-
dc.contributor.authorCorbett, A-
dc.contributor.authorBallard, C-
dc.contributor.authorWilliams, J-
dc.contributor.authorMurphy, K-
dc.contributor.authorChandler, H-
dc.date.accessioned2024-02-04T10:38:27Z-
dc.date.available2024-02-04T10:38:27Z-
dc.date.issued2023-12-21-
dc.identifierORCID iD: Byron Creese https://orcid.org/0000-0001-6490-6037-
dc.identifier213-
dc.identifier.citationLancaster, T. et al. (2023) 'Proof-of-concept recall-by-genotype study of extremely low and high Alzheimer’s polygenic risk reveals autobiographical deficits and cingulate cortex correlates', Alzheimer's Research and Therapy, 15, 213, pp. 1 - 10. doi: 10.1186/s13195-023-01362-y.en_US
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/28201-
dc.descriptionAvailability of data and materials: The wider genetic data that support the findings of this study are available from the PROTECT cohort, but restrictions apply to the availability of these data, which were used under licence for the current study, and so are not publicly available. The behaviour / MRI datasets generated and/or analysed during the current study are not publicly available as participants did not consent to public data sharing, but code supporting all inferences are available from the corresponding author on reasonable request.en_US
dc.descriptionEthics declarations: Ethics approval and consent to participate. All participants were recruited to the wider PROTECT study, provided informed consent (www.protectstudy.org.uk; Research Ethics Committee reference number 13/LO/1578). All participants that were invited for the MRI study provided informed consent via approval by the Department of Psychology at Cardiff University (EC.18.12.11.5510GR2).-
dc.description.abstractBackground: Genome-wide association studies demonstrate that Alzheimer’s disease (AD) has a highly polygenic architecture, where thousands of independent genetic variants explain risk with high classification accuracy. This AD polygenic risk score (AD-PRS) has been previously linked to preclinical cognitive and neuroimaging features observed in asymptomatic individuals. However, shared variance between AD-PRS and neurocognitive features are small, suggesting limited preclinical utility. Methods: Here, we recruited sixteen clinically asymptomatic individuals (mean age 67; range 58–76) with either extremely low / high AD-PRS (defined as at least 2 standard deviations from the wider sample mean (N = 4504; N EFFECTIVE = 90)) with comparable age sex and education level. We assessed group differences in autobiographical memory and T1-weighted structural neuroimaging features. Results: We observed marked reductions in autobiographical recollection (Cohen’s d =  − 1.66; P FDR = 0.014) and midline structure (cingulate) thickness (Cohen’s d =  − 1.55, P FDR = 0.05), with no difference in hippocampal volume (P > 0.3). We further confirm the negative association between AD-PRS and cingulate thickness in a larger study with a comparable age (N = 31,966, β =  − 0.002, P = 0.011), supporting the validity of our approach. Conclusions: These observations conform with multiple streams of prior evidence suggesting alterations in cingulate structures may occur in individuals with higher AD genetic risk. We were able to use a genetically informed research design strategy that significantly improved the efficiency and power of the study. Thus, we further demonstrate that the recall-by-genotype of AD-PRS from wider samples is a promising approach for the detection, assessment, and intervention in specific individuals with increased AD genetic risk.en_US
dc.description.sponsorshipTL acknowledges funding via Ser Cymru II fellowship [PNU-80762-CU-14]. HC & ID funded by Wellcome Strategic Award [104943/Z/14/Z]. HC, ID, and KM are funded by a Wellcome Senior Fellowship [WT200804 and WT224267]. BC is funded in part through the MRC Proximity to Discovery: Industry Engagement Fund (External Collaboration, Innovation and Entrepreneurism: Translational Medicine in Exeter 2 (EXCITEME2) ref. MC_PC_17189). VE-P acknowledges funding received from a Medical Research Council grant (MR/L010305/1). This work is supported by the UK Dementia Research Institute which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council (UKDRI-3003), Alzheimer’s Society and Alzheimer’s Research UK.en_US
dc.format.extent1 - 10-
dc.format.mediumElectronic-
dc.languageEnglish-
dc.language.isoenen_US
dc.publisherBiomed Central (part of Springer Nature)en_US
dc.rightsCopyright © The Author(s) 2023. Rights and permissions: Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectpolygenic risk scoreen_US
dc.subjectAlzheimer’s diseaseen_US
dc.subjectrecall-by-genotypeen_US
dc.subjectneuroimagingen_US
dc.titleProof-of-concept recall-by-genotype study of extremely low and high Alzheimer’s polygenic risk reveals autobiographical deficits and cingulate cortex correlatesen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1186/s13195-023-01362-y-
dc.relation.isPartOfAlzheimer's Research and Therapy-
pubs.issue1-
pubs.publication-statusPublished-
pubs.volume15-
dc.identifier.eissn1758-9193-
dc.rights.holderThe Author(s)-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © The Author(s) 2023. Rights and permissions: Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.1.56 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons